State of New Jersey Common Pension Fund D - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of New Jersey Common Pension Fund D ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,000,228
+1.9%
78,540
-3.8%
0.01%
+10.0%
Q2 2023$2,943,925
-5.6%
81,6170.0%0.01%
-9.1%
Q1 2023$3,116,953
-32.9%
81,6170.0%0.01%
-38.9%
Q4 2022$4,644,007
+43.9%
81,6170.0%0.02%
+38.5%
Q3 2022$3,227,000
-10.1%
81,6170.0%0.01%
-7.1%
Q2 2022$3,591,000
+10.3%
81,6170.0%0.01%
+40.0%
Q1 2022$3,255,000
-0.8%
81,6170.0%0.01%
+11.1%
Q4 2021$3,282,000
-4.1%
81,617
-3.0%
0.01%
-18.2%
Q3 2021$3,423,000
-6.1%
84,140
+4.8%
0.01%
-8.3%
Q2 2021$3,646,000
+9.1%
80,293
+0.2%
0.01%0.0%
Q1 2021$3,341,000
-18.6%
80,150
-16.6%
0.01%
-20.0%
Q4 2020$4,106,000
+55.1%
96,138
-4.6%
0.02%
+50.0%
Q3 2020$2,647,000
-6.2%
100,726
-4.3%
0.01%
-16.7%
Q2 2020$2,822,000
+26.2%
105,249
-15.4%
0.01%
+9.1%
Q1 2020$2,237,000
+1.5%
124,3600.0%0.01%
+37.5%
Q4 2019$2,205,000
-0.2%
124,360
-12.7%
0.01%
-11.1%
Q3 2019$2,210,000
-49.6%
142,500
-44.1%
0.01%
-43.8%
Q2 2019$4,381,000
+6.7%
255,0000.0%0.02%
+6.7%
Q1 2019$4,106,000
+10.1%
255,0000.0%0.02%
-6.2%
Q4 2018$3,731,000
-19.5%
255,0000.0%0.02%
-5.9%
Q3 2018$4,633,000
+7.7%
255,0000.0%0.02%
+6.2%
Q2 2018$4,302,000
-13.9%
255,0000.0%0.02%
-15.8%
Q1 2018$4,995,000
-3.3%
255,0000.0%0.02%
-5.0%
Q4 2017$5,166,000
+16.6%
255,0000.0%0.02%
+11.1%
Q3 2017$4,429,000
+91.9%
255,000
+41.7%
0.02%
+100.0%
Q2 2017$2,308,000
-1.1%
180,0000.0%0.01%
-10.0%
Q1 2017$2,333,000
+31.2%
180,0000.0%0.01%
+25.0%
Q4 2016$1,778,000
-18.2%
180,0000.0%0.01%
-11.1%
Q3 2016$2,174,000
+40.0%
180,0000.0%0.01%
+28.6%
Q2 2016$1,553,000
-8.9%
180,0000.0%0.01%
-12.5%
Q1 2016$1,705,000
-72.7%
180,000
-50.0%
0.01%
-38.5%
Q4 2015$6,238,000
+158.1%
360,000
+100.0%
0.01%
+30.0%
Q3 2015$2,417,000
-40.5%
180,0000.0%0.01%
-37.5%
Q2 2015$4,064,000
+58.1%
180,0000.0%0.02%
+60.0%
Q1 2015$2,570,000
+48.0%
180,0000.0%0.01%
+42.9%
Q4 2014$1,737,000
+6.0%
180,0000.0%0.01%
+16.7%
Q3 2014$1,638,000
-7.9%
180,0000.0%0.01%
-14.3%
Q2 2014$1,778,000180,0000.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders